Traditional Chinese Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global Traditional Chinese Medicine (TCM) Market, valued at approximately US$ 32 billion in 2024, is reaching a projected valuation of around US$ 47 billion by the end of 2031. The market's growth is driven by increasing demand for TCM formulations, advancements in research and development, and rising awareness of traditional therapies.
Key Factors Driving Market Growth
1. TCM Formulations Research: Research initiatives, new regulations, expanded funding options, and public-private partnerships are fostering innovative research opportunities in TCM medication formulations. Extracts from medicinal plants like Poria cocos, Panax ginseng, and Schisandra chinensis are gaining attention, driving demand for these TCM formulations.
2. Rising Health Concerns: The global need for TCM treatment is growing due to an increase in pediatric disorders, chronic behavioral diseases, heightened awareness of mental health, and lifestyle diseases like ASD and ADHD. TCM practices such as nutritional treatment, acupuncture, and massage are being used alongside conventional therapies to treat various diseases.
3. Regional Growth: Developing countries in the Asia Pacific and East Asian regions are witnessing increased demand for low-cost TCM due to a growing local pharmaceutical manufacturing sector. Government initiatives in countries like China, India, Africa, and Brazil are boosting the production of TCM and non-TCM drugs and associated healthcare services.
Market Growth Challenges
1. Inadequate Supply of High-Quality TCM Formulations: Despite the demand, there is a significant supply gap for high-quality herbal extracts and excipients necessary for developing plant-based medications.
Booming United States Market
Traditional medicine, including TCM, has been steadily expanding in the United States. TCM practices are preferred for managing chronic health issues and improving overall quality of life due to their minimal to no evident negative effects and cost-effectiveness.
Lucrative United Kingdom Market
The United Kingdom is experiencing growth in TCM practices such as acupuncture, Chinese herbal medicines, and moxibustion, contributing to the market's expansion.
Prominence of China
In China, TCM is widely preferred over Western medicine due to perceptions of fewer negative effects and a healing effect on the body. This contributes significantly to the growth of the TCM market.
Competitive Landscape
Leading players in the TCM market are focusing on exclusive distributorships for research and development, manufacturing, and commercial purposes.
Key Companies Profiled:
• Zhongxin Pharmaceuticals
• Tianjin Tasly Group
• Yuannan Baiyao
• Solstice Medicine Company, Inc.
• Shanghai Sundise Traditional Chinese Medicine Co., Ltd
• Chinese Medicine Holding Co., Ltd.
• Hunan goldliloo pharmaceutical Co., Ltd
• Wanbang Pharma Group Corp.
• Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
• Pfizer Inc.
• Eli Lilly and Company
• Novartis AG
• GlaxoSmithKline PLC
• Mallinckrodt Pharmaceuticals
• Hisamitsu Pharmaceutical Co., Inc.
• Tongrentang
The global Traditional Chinese Medicine market is poised for substantial growth, driven by increasing research, rising health concerns, and expanding markets in regions such as the United States, the United Kingdom, and China.
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.